Search Results - "Moormann, R.J"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus by Loeffen, W.L.A, de Vries, R.P, Stockhofe, N, van Zoelen-Bos, D, Maas, R, Koch, G, Moormann, R.J, Rottier, P.J.M, de Haan, C.A.M

    Published in Vaccine (11-02-2011)
    “…Abstract In 2009 a new influenza A/H1N1 virus strain (“pandemic (H1N1) 2009”, H1N1v) emerged that rapidly spread around the world. The virus is suspected to…”
    Get full text
    Journal Article
  2. 2

    Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines by Loeffen, W.L.A., Stockhofe, N., Weesendorp, E., van Zoelen-Bos, D., Heutink, R., Quak, S., Goovaerts, D., Heldens, J.G.M., Maas, R., Moormann, R.J., Koch, G.

    Published in Veterinary microbiology (28-09-2011)
    “…In April 2009 a new influenza A/H1N1 strain, currently named “pandemic (H1N1) influenza 2009″ (H1N1v), started the first official pandemic in humans since…”
    Get full text
    Journal Article
  3. 3

    Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination by de Smit, A.J, Bouma, A, de Kluijver, E.P, Terpstra, C, Moormann, R.J.M

    Published in Veterinary microbiology (26-02-2001)
    “…The period during which pigs are protected after vaccination is important for the successful usage of a marker vaccine against classical swine fever virus…”
    Get full text
    Journal Article
  4. 4

    Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs by de Smit, A.J, Bouma, A, van Gennip, H.G.P, de Kluijver, E.P, Moormann, R.J.M

    Published in Vaccine (08-01-2001)
    “…Two live recombinant vaccines (Flc9 and Flc11) against classical swine fever (CSF) were evaluated for their capacity to reduce transmission of virulent CSF…”
    Get full text
    Journal Article
  5. 5

    Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response by Gennip, H.G., van, Rijn, P.A., van, Widjojoatmodjo, M.N, Smit, A.J., de, Moormann, R.J

    Published in Vaccine (2000)
    “…Three chimeric classical swine fever virus (CSFV)/bovine viral diarrhoea virus (BVDV) full-length DNA copies were constructed, based on the infectious DNA copy…”
    Get full text
    Journal Article
  6. 6

    Development of a classical swine fever subunit marker vaccine and companion diagnostic test by Moormann, R.J, Bouma, A, Kramps, J.A, Terpstra, C, Smit, H.J., de

    Published in Veterinary microbiology (2000)
    “…The development of a classical swine fever (CSF) subunit marker vaccine, based on viral envelope glycoprotein E2, and a companion diagnostic test, based on a…”
    Get full text
    Journal Article
  7. 7

    Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine by Smit, A.J. de, Bouma, A, Kluijver, E.P. de, Terpstra, C, Moormann, R.J.M

    Published in The Veterinary quarterly (01-07-2000)
    “…The use of a vaccine against classical swine fever virus (CSFV) during an outbreak of CSF should lead to a reduction in the horizontal or vertical transmission…”
    Get full text
    Journal Article
  8. 8

    Interaction between chicken anaemia virus and live Newcastle disease vaccine by De Boer, G.F., Van Roozelaar, D.J., Moormann, R.J., Jeurissen, S.H.M., Van Den Wijngaard, J.C., Hilbink, F., Koch, G.

    Published in Avian pathology (01-06-1994)
    “…Three groups of 150 SPF chickens were spray-vaccinated with live Newcastle disease La Sota-type vaccine (clone 30) at one day of age, and another three groups…”
    Get full text
    Journal Article